ETUDE PHARMACOLOGIQUE DE LHYDROXYZINE UCB 492, DERIVE DISUBSTITUE DE LA PIPERAZINE

[1] BEIN HJ, 1951, SCHWEIZ MED WSCHR, V81, P447

[2] BRAND ED, 1954, J PHARMACOL EXP THER, V110, P86

[3] BULBRING E, 1945, J PHARMACOL EXP THER, V85, P78

[4] BURN JH, 1948, BACKGROUNDS THERAPEU, P275

[5] BURN JH, 1950, BIOL STANDARDIZATION, P325

[6] Chance MRA, 1944, J PHARMACOL EXP THER, V82, P203

[7] COURVOISIER S, 1953, ARCH INT PHARM, V92, P349

[8] DOMENJOZ R., 1952, ARCH EXPTL PATH U PHARMAKOL, V215, P19

[9] ERCOLI N, 1945, J PHARMACOL EXP THER, V84, P301

[10] Gellhorn E, 1943, J NEUROPHYSIOL, V6, P161

[1] BEIN HJ, 1951, SCHWEIZ MED WSCHR, V81, P447

[2] BRAND ED, 1954, J PHARMACOL EXP THER, V110, P86

[3] BULBRING E, 1945, J PHARMACOL EXP THER, V85, P78

[4] BURN JH, 1948, BACKGROUNDS THERAPEU, P275

[5] BURN JH, 1950, BIOL STANDARDIZATION, P325

[6] Chance MRA, 1944, J PHARMACOL EXP THER, V82, P203

[7] COURVOISIER S, 1953, ARCH INT PHARM, V92, P349

[8] DOMENJOZ R., 1952, ARCH EXPTL PATH U PHARMAKOL, V215, P19

[9] ERCOLI N, 1945, J PHARMACOL EXP THER, V84, P301

[10] Gellhorn E, 1943, J NEUROPHYSIOL, V6, P161